Andere talen Cipla Limited

Aandelen

Beurs gesloten - NSE India S.E. Andere beurzen 13:43:53 25-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1.500 ^INR	-0,31%		-4,77%	+20,33%

25/06	US FDA classificeert inspectie van Cipla's Patalganga productiefaciliteit als vrijwillige actie aangegeven	MT
24/06	INDIA STOCKS-Indiase aandelen openen lager; small-caps, mid-caps dalen	RE

US FDA Classifies Inspection of Cipla's Patalganga Manufacturing Facility as Voluntary Action Indicated	25/06
INDIA STOCKS-Financials weigh on Indian shares; small-, mid-caps fall	24/06
Indian shares set to open lower; small-caps, mid-caps in focus	24/06
Cipla Gets Six US FDA Observations after Goa, India Unit Inspection	24/06
Les sorcières épouvantent l'IA	21/06
En Direct des Marchés : LVMH, Accor, Alstom, Atos, Casino, Plastivaloire, Boeing, Geberit...	21/06
Borsa di Italia: Le streghe terrorizzano l'AI	21/06
Bolsa de Madrid: Las brujas aterrorizan a la IA	21/06
Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India	21/06
Cipla : signs a non-exclusive patent license agreement with Takeda to commercialize Vonoprazan drug in India	20/06
Cipla EU to invest an additional EUR 3 million in Ethris	19/06
Cipla to Invest Additional 3 Million Euros in Germany's Ethris	18/06
Indian Equities End Lower on Monday, Mainly Weighed Down by IT Stocks	10/06
Cipla's Global Chief Technology Officer Retires	31/05
India's pharma export sales to grow faster this year, trade body says	30/05
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research	27/05
Qcil Records 68 Percent Growth in Net Profit to Shs32 Billion	23/05
Consumer Goods, Realty Push Indian Equities Higher on Wednesday	22/05
Cipla Arm Gets US FDA Final Nod for Lanreotide Injection	22/05
Cipla Limited Approves the Appointment of Dr. Balram Bhargava as an Independent Director	17/05

Geen resultaten voor deze zoekopdracht